Pearce IP Expands Life Sciences Patent Expertise with Addition of Sarah Dieckmann

Pearce IP, a specialist intellectual property law firm focused on life sciences, has announced the appointment of Sarah Dieckmann as an Associate and Foreign Registered Patent Attorney. This strategic hire strengthens the firm’s expertise in biotechnology and life sciences intellectual property.

Sarah Dieckmann brings more than 10 years of experience in intellectual property law, complemented by a PhD in Biology. Her extensive international background includes qualifications as a German Patent Attorney and European Patent Attorney, as well as senior in-house patent counsel experience at a global consumer goods company.

Her career spans both private practice and industry roles, enabling her to provide clients with commercially focused IP advice grounded in legal expertise and practical business experience. Dieckmann advises biotechnology and life sciences companies throughout the entire patent lifecycle, including patent drafting and prosecution, opposition proceedings, freedom-to-operate assessments, portfolio management, and strategic IP counsel.

She has particular expertise in molecular biology, microbiology, enzyme technology, and genetics. This technical proficiency allows her to assist innovators in developing intellectual property strategies that facilitate commercialisation, attract investment, and support long-term growth.

Dieckmann’s appointment aligns with Pearce IP’s ongoing commitment to delivering specialist intellectual property advice to pharmaceutical, biopharmaceutical, and life sciences sectors across Australia, New Zealand, and international jurisdictions.

Expressing enthusiasm about joining Pearce IP, Dieckmann stated, “I am excited to join Pearce IP and work alongside a team recognised for its deep expertise in life sciences intellectual property. I look forward to helping innovative companies protect and maximise the value of their inventions as they develop and commercialise new technologies.”

Pearce IP’s CEO and Founder, Naomi Pearce, who holds qualifications as an Executive Lawyer and Patent and Trade Mark Attorney in Australia and New Zealand, commented on the appointment: “Sarah’s combination of scientific expertise, international patent experience and commercial insight makes her an outstanding addition to our team. Her appointment further strengthens our ability to support biotechnology and life sciences clients with sophisticated intellectual property strategies across global markets.”

Pearce IP is a privately owned, independent intellectual property law firm with a focus on life sciences. Its team of lawyers and attorneys specialise in pharmaceutical, biopharmaceutical, biotechnology, agricultural technology, food technology, and medical technology sectors, though their work extends beyond these industries.

In 2025, Pearce IP was recognised by Australasian Lawyer and New Zealand Lawyer as a Top Specialist Firm and a 5 Star Employer of Choice. The firm also received the “Standout Winner” award for Inclusion and Culture among firms with fewer than 100 employees. Pearce IP and its leadership are consistently ranked in leading legal directories including Chambers & Partners, Legal 500, IAM Patent 1000, IAM Strategy 300, MIP IP Stars, Doyles Guide, WTR 1000, Best Lawyers, WIPR Leaders, and Best Law Firms.

Notably, Pearce IP is the only leading intellectual property firm in Australia and New Zealand founded by a woman and is certified by WEConnect International as women-owned.

For further information about Sarah Dieckmann and her professional background, Pearce IP encourages contact via sarah.dieckmann@pearceIP.law or through her professional profile on the firm’s website.